John Paulson acquired 1.78 Million Madrigal Pharmaceuticals shares worth $374 Million. It makes up 30.45% of their stock portfolio and is their biggest holding. The investor owns 8.49% of the outstanding Madrigal Pharmaceuticals stock. The investor's estimated purchase price is $387 Million, resulting in a loss of 3.2%.
Paulson & Co. exits Newmont stake, increases holdings in Horizon Therapeutics and Madrigal Pharma.
Seeking Alpha, 6 months agoIn this article, we discuss billionaire John Paulson’s Messy divorce and top 5 stock picks. If you want to see more stocks in this selection, check out Billi...
Insider Monkey, 6 months agoPaulson & Co., the fund headed by John Paulson, added new stakes in Iveric Bio (ISEE) (25K shares), Madrigal Pharmaceuticals (MDGL) (350K shares), and Newmon...
Seeking Alpha, 9 months ago